Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ASO Author Reflections: Germline Testing for All Patients With Breast Cancer: Has the Time Finally Come?

Annals of surgical oncology - 1 Feb 2022

Mittal Abhenil, Pramanik Raja

Abstract excerpt

For the young breast cancer population in India, the burden of hereditary breast cancer is not well defined. Moreover, genetic testing criteria (National Comprehensive Cancer Network and Mainstreaming Cancer Genetics (MCG) plus) have never been validated for the Indian population. Therefore, this study tested 236 consecutive breast cancer patients for germline pathogenic mutations using next-generation sequencing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein
Share to BRCA2 Protein
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Germ Cells

Share to Germ-Line Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 34654988
DOI: 10.1245/s10434-021-10880-8
PMCID: PMC8519625

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ASO Author Reflections: Germline Testing for All Patients With Breast Cancer: Has the Time Finally Come?PMID 34654988Read ↗

Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center.Semantic proximity Read ↗

A Decade of Hereditary Cancer Genetic Testing Results in Asian Indian population: Retrospective StudySemantic proximity Read ↗

Recent Advances in Genetic Testing and Clinical Management of Hereditary Breast and Ovarian Cancer (HBOC) in India.Semantic proximity Read ↗

Germline mutational landscape in a large cohort of Indian breast cancer.Semantic proximity Read ↗

Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.Semantic proximity Read ↗

Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India.Semantic proximity Read ↗

Canadian Recommendations for Germline Genetic Testing of Patients with Breast Cancer: A Call to ActionSemantic proximity Read ↗

Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test?Semantic proximity Read ↗

Universal genetic testing of patients with newly diagnosed breast cancer - ready for prime time?Semantic proximity Read ↗

Understanding the genetic epidemiology of hereditary breast cancer in India using whole genome data from 1029 healthy individualsSemantic proximity Read ↗

Assessing germline mutational profile and its clinicopathological associations in Triple Negative Breast CancerSemantic proximity Read ↗

Assessing germline mutational profile and its clinicopathological associations in Triple Negative Breast CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.